SprintRay, a leader in dental 3D printing technology, has taken a significant step forward in its mission to transform digital dentistry with the acquisition of the EnvisionTEC/ETEC dental product portfolio. This acquisition encompasses a diverse range of patents, trademarks, inventory, and intellectual property related to dental materials and 3D printing technologies, previously under the Desktop Health brand. The move signals SprintRay’s commitment to advancing the capabilities of dental professionals through reliable, high-performance hardware and clinically validated materials.
EnvisionTEC has long been recognized as a pioneer in dental 3D printing. Over the past two decades, the company has amassed more than 200 patents covering both hardware and materials, and has built a loyal customer base among dental labs and practices worldwide. Its innovations include the patented cDLM (continuous digital light manufacturing) technology featured in the Envision One platform, as well as the Einstein DLP printer line developed under Desktop Health. These systems have been widely adopted for their precision, speed, and versatility in producing dental prosthetics and appliances.
Among the most notable assets in the acquisition is Flexcera, a hybrid nanoceramic resin that has earned FDA 510(k) Class II clearance, CE Mark certification, and MDR Class I designation. Flexcera is known for its strength, aesthetics, and biocompatibility, making it a preferred material for printing dental prosthetics. By bringing this resin and other proprietary materials into its portfolio, SprintRay is expanding its ability to support both chairside and laboratory workflows with a broader range of clinically approved options.
The integration of EnvisionTEC’s technologies into SprintRay’s ecosystem is not just about expanding product lines. It is about creating a more seamless and robust experience for dental professionals. SprintRay has outlined several key initiatives to ensure continuity and enhance value for existing users of EnvisionTEC and Desktop Health systems. These include maintaining dedicated customer support to minimize disruption, continuing the production of essential resins like Flexcera to ensure a consistent supply, and validating cross-platform compatibility between SprintRay and EnvisionTEC systems. This thoughtful approach reflects SprintRay’s understanding of the critical role that reliability and support play in clinical environments.
Beyond immediate operational priorities, the acquisition positions SprintRay to lead innovation in dental lab applications. EnvisionTEC’s technologies have long been favored by labs for their ability to handle complex cases and high-volume production. By integrating these capabilities, SprintRay is strengthening its presence in the lab segment and setting the stage for new standards in efficiency, precision, and material performance.
This acquisition also reflects a broader trend in digital dentistry, where consolidation and strategic partnerships are driving the next wave of innovation in the field. As practices and labs seek more integrated solutions that combine hardware, software, and materials, companies like SprintRay are stepping up to deliver comprehensive platforms that meet the evolving demands of modern dental care.
KEY QUOTE:
“SprintRay’s acquisition of EnvisionTEC’s dental portfolio ensures existing customers continue to have the tools and support they rely on, while also strengthening our position in dental labs. Our mission to transform dentistry through accessible, reliable 3D printing technology hasn’t wavered. This strategic move reinforces that commitment.”
Amir Mansouri, PhD, SprintRay Co-founder and CEO
